teaser
↓Article continues below this sponsored advert↓
↑Advertisement↑
GlaxoSmithKline intends to spend $40m this year on its new facility in Shanghai, China, which is expected to become one of the drug major
Published on 5 July 2007
GSK in $40m China investment
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
